Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ...

As the STEM program at Cochranton Junior-Senior High in Pennsylvania expands, all students will be able to earn a STEM certificate in addition to their diploma through courses like applied engineering ...

Shoals Technologies faces a temporary margin trough from tariffs, mix, and manufacturing shifts, with strong demand ...

Four years of an aggressive turnaround effort by former CEO Pat Gelsinger to revive Intel's manufacturing arm by opening it ...

AI only creates lasting value when it is woven into the flow of work. Retail and CPG companies must redesign processes so AI ...

Intel Corp. shares fell Wednesday after a report said that Nvidia Corp. halted a test to use Intel’s production process to ...

For decades, Georgia’s economic success has depended on a steady flow of talented, hardworking people from around the world.

Indian American researcher Sridhar Seetharaman is an expert on decarbonization and energy savings in industrial processes ...

Understanding Liability and Safety Risks After Semi-Truck Tire Blowouts in Georgia Valdosta, United States – December 17, ...

India and New Zealand have successfully concluded a comprehensive Free Trade Agreement, marking a significant milestone in ...

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...